Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

A Masquerading Solitary Skin Lesion: Unusual Presentation of Multibacillary Leprosy with Dermoscopic Assistance in Diagnosis.

Kumar Kansal N, Joshi PP, Dhanta A, et al. Indian dermatology online journal. 2020; 11 (4) : 632-634.
Download PDF
Publication

Household Contacts of Leprosy Patients in Endemic Areas Display a Specific Innate Immunity Profile.

van Hooij A, Tió-Coma M, Verhard E, et al. Frontiers in immunology. 2020;
Download PDF
Publication

Association of IL-10 Gene Polymorphism With IL-10 Secretion by CD4 and T Regulatory Cells in Human Leprosy.

Tarique M, Naz H, Saini C, et al. Frontiers in immunology. 2020;
Download PDF
Publication

Persistent plaques after release from treatment in slit-skin smear negative leprosy patients: wait and watch or adopt a proactive approach?

Narang T, Bishnoi A, Thakur V, et al. Dermatologic therapy. 2020;
Publication

Leprosy Post-Exposure Prophylaxis with Single-dose Rifampicin. Health economic aspects in India

Tiwari A. Erasmus University. Department of Public Health. 2020;
Download PDF
Publication

Profil Penderita Morbus Hansen (MH) di Poliklinik Kulit dan Kelamin RSUP Prof. Dr. R. D. Kandou Manado Periode Januari – Desember 2013

Desrina A, Kapantow GM, Kandou RT. e-CliniC. 2020; 8 (2) : 199-202.
Download PDF
Publication

Ocular erythema nodosum leprosum: An immunohistochemical study

Rathinam S, Parikh J, Rao N. Medknow. Indian Journal of Ophthalmology. 2020; 68 (9) : 2028.
Download PDF
Publication

Anterior chamber angle granuloma: A rare ocular manifestation of histoid lepromatous leprosy

Karkhur S, Soni D, Sharma B. Medknow. Indian Journal of Ophthalmology. 2020; 68 (9) : 2031.
Download PDF
Publication

Ganglionitis and myelitis: myriad neurological manifestations of Hansen's disease.

Bafna P, Sahoo R, Manoj M, et al. BMJ case reports. 2020;
Download PDF
Publication

Multibacillary Leprosy Presenting as Anetoderma in a Young Teenager.

Parajuli N, Shrestha S, Lama L, et al. Case reports in dermatological medicine. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 112
  • Next page ››
Subscribe to South-East Asia Region (SEAR)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD